AstraZeneca To Invest $1.5b To Manufacture Cancer Killer In Singapore

AstraZeneca To Invest $1.5b To Manufacture Cancer Killer In Singapore

AstraZeneca says it  will invest 1.5 billion U.S. dollars in building a manufacturing facility in Singapore for antibody drug conjugates (ADCs). The biopharmaceutical...